"Slide in Novo Nordisk and Orsted shares make Denmark one of the worst-performing stock markets in the world this year.
With a 41% weighting in the index, Novo Nordisk's decline drives Danish market losses, highlighting concentration risk.
The Morningstar Denmark Index is now undervalued, trading at a 20% discount.
US-Denmark tensions add geopolitical risk, affecting companies like Orsted.
With the Morningstar Denmark Index as the worst-performing Morningstar index this year, across both developed and emerging markets, Danish stocks may now appear to offer compelling value for long-term investors. The Danish index is down 20.7% so far in 2025 and 38.4% in the past 12 months.
Morningstar New Zealand Index, the second worst performing developed market index, is down 0.2% in the same period. When looking at emerging markets, Morningstar Thailand Index has lost 3.7% followed by Morningstar Malaysia Index, reporting a 1.8% loss. All return data are in base currency.
"The previously high-flying Danish economy has had its wings clipped as historical growth figures have been revised lower and industrial production has declined, particularly in the pharmaceutical sector," says Jan Størup Nielsen, chief analyst at Nordea".
Læs hele den læseværdige artiklen fra Morningstar:
https://global.morningstar.com/en-nd/markets/is-now-good-time-buy-danish-stocks
With a 41% weighting in the index, Novo Nordisk's decline drives Danish market losses, highlighting concentration risk.
The Morningstar Denmark Index is now undervalued, trading at a 20% discount.
US-Denmark tensions add geopolitical risk, affecting companies like Orsted.
With the Morningstar Denmark Index as the worst-performing Morningstar index this year, across both developed and emerging markets, Danish stocks may now appear to offer compelling value for long-term investors. The Danish index is down 20.7% so far in 2025 and 38.4% in the past 12 months.
Morningstar New Zealand Index, the second worst performing developed market index, is down 0.2% in the same period. When looking at emerging markets, Morningstar Thailand Index has lost 3.7% followed by Morningstar Malaysia Index, reporting a 1.8% loss. All return data are in base currency.
"The previously high-flying Danish economy has had its wings clipped as historical growth figures have been revised lower and industrial production has declined, particularly in the pharmaceutical sector," says Jan Størup Nielsen, chief analyst at Nordea".
Læs hele den læseværdige artiklen fra Morningstar:
https://global.morningstar.com/en-nd/markets/is-now-good-time-buy-danish-stocks
God artikel. Coloplast har fået fem Morningstar-stjerner. Den ville jeg selv have givet fire. Den er i mine øjne stadig for dyr, hvis den nuværende ROIC og vækst er repræsentativ for fremtiden.
Jeg har linket til siden før, men blandt andet her kan man se PE-værdier for forskellige lande:
https://worldperatio.com/
Hov, der kom vist et screenshot med, der ikke skulle have været med. Jeg håber ikke, at det viser en pop-up-notifikation fra OnlyFans eller lignende.
Jeg har linket til siden før, men blandt andet her kan man se PE-værdier for forskellige lande:
https://worldperatio.com/
Hov, der kom vist et screenshot med, der ikke skulle have været med. Jeg håber ikke, at det viser en pop-up-notifikation fra OnlyFans eller lignende.
20/9 2025 06:46 Helge Larsen/PI-redaktør 1
128497 Servicemeddelelse: Klik på billederne for at forstørre.
Servicemeddelelse: På onsdag den 24/9 giver jeg mit perspektiv på hvordan de danske aktier kan få et comeback. Hvad det kræver og hvorfor tingene er som de er aktuelt. Det sker i Fredericia: https://www.shareholders.dk/DAF-TALKS. Måske ses vi der - Hilsen Per
Der var kommet et punktum med i URLen:
https://www.shareholders.dk/DAF-TALKS
Jeg skal sandsynligvis købe danske aktier de næste årtier, så jeg håber de falder endnu mere. Men jeg synes Novo Nordisk, Genmab, Pandora, Ørsted og andre er interessante til den nuværende kurs. Analytikerne hos Morningstar synes tilsyneladende det samme. Jeg håber Coloplast falder yderligere, så jeg kan diversificere en smule. Ellers tror jeg, at jeg snart ender med flere Novo-aktier end fonden.
https://www.shareholders.dk/DAF-TALKS
Jeg skal sandsynligvis købe danske aktier de næste årtier, så jeg håber de falder endnu mere. Men jeg synes Novo Nordisk, Genmab, Pandora, Ørsted og andre er interessante til den nuværende kurs. Analytikerne hos Morningstar synes tilsyneladende det samme. Jeg håber Coloplast falder yderligere, så jeg kan diversificere en smule. Ellers tror jeg, at jeg snart ender med flere Novo-aktier end fonden.
